title: Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis.
abstract: It is remarkable that certain patients with heterozygous protein C (PC) deficiency manifest venous thromboembolism (VTE), whereas others, particularly those belonging to families with homozygous PC deficiency, remain asymptomatic. The goals of the present study of a family, in which the proband had homozygous PC deficiency, were to identify members with and without VTE, to determine the mutation causing PC deficiency, and to search for the R506Q mutation of factor V (FV) causing activated PC resistance. Heterozygosity for a T298M mutation in exon 9 of the PC gene was found in the father of the homozygous proband who died of massive thrombosis. Based on analysis of a three-dimensional molecular model of PC, we speculate that this mutation causes type I deficiency due to disruption of packing of hydrophobic side chains and loss of an H-bond between Q184 and T298. Forty-six family members were examined for the T298M mutation by polymerase chain reaction (PCR) amplification of exon 9 and restriction analysis using Mae III and for the FV R506Q mutation by PCR amplification of exon 10 and restriction analysis using Mnl I. VTE was observed in five of 11 members who were heterozygous for both PC and FV mutations. In contrast, VTE was not observed for the PC mutation in 13 heterozygotes who had normal FV, including the parents of the deceased proband, 10 heterozygotes for the FV mutation who had normal PC, and 12 individuals bearing neither mutation. These observations extend recent evidence of an increased thrombotic risk conferred by the coexistence of heterozygous PC deficiency and heterozygous activated PC resistance and support the paradigm in which hereditary thrombophilia is often a multigenic disease.
authors.affiliation: Department of Hematology, Rambam Medical Center, Haifa, Israel.
authors.forename: B
authors.initials: B
authors.lastname: Brenner
authors.forename: A
authors.initials: A
authors.lastname: Zivelin
authors.forename: N
authors.initials: N
authors.lastname: Lanir
authors.forename: J S
authors.initials: JS
authors.lastname: Greengard
authors.forename: J H
authors.initials: JH
authors.lastname: Griffin
authors.forename: U
authors.initials: U
authors.lastname: Seligsohn
mesh_terms: D000328:Adult; D001483:Base Sequence; D003241:Consanguinity; D004198:Disease Susceptibility; D005165:Factor V / Q000235:genetics*; D005166:Factor V Deficiency / Q000235:genetics*; D005260:Female; D018740:Genetic Heterogeneity; D006579:Heterozygote; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D010375:Pedigree; D011486:Protein C / Q000235:genetics*; D013924:Thrombophlebitis / Q000235:genetics*; D013927:Thrombosis / Q000151:congenital / Q000235:genetics
chemical_list: D011486:Protein C; D005165:Factor V